Novavax, Inc. (NVAX) on Thursday announced preclinical data demonstrating that the company’s H5N1 bird flu vaccine candidate induced robust immune responses in nonhuman primates. H5N1 is a highly ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the body's own immune system to fight tumors.

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

One dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Scientists turn dental floss into a vaccine tool that protected mice from lethal flu and triggered widespread immune response ...

New research reveals that tiny amounts of PFAS—widely known as "forever chemicals"—cross the placenta and breast milk to ...

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

The fatality rate for H5N1 highly pathogenic avian influenza in humans historically has been high, with more than half of people dying. Why, then, is the current H5N1 bird flu outbreak — which has ...

The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...